Evolent Health stock falls 7% on revenue miss despite in-line earnings

Evolent Health Inc. (NYSE:EVH) reported third quarter results that missed revenue expectations, leading to a 7.29% drop in its shares in pre-market trading. The healthcare solutions company posted adjusted earnings per share of $0.06, in line with analyst expectations, while revenue of $725.37 million fell short of the consensus estimate of $727.06 million.

Despite the revenue miss, the company reiterated its full-year 2026 revenue guidance of $2.6 billion to $2.7 billion, with the midpoint slightly above the analyst consensus. Evolent's CEO, Seth Blackley, attributed the company's growth to renewed agreements with health plan customers and strong execution in 2026 oncology launches.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.